Land Securities Group Plc (OTCMKTS:LDSCY) Short Interest Down 66.7% in November
by Doug Wharley · The Cerbat GemLand Securities Group Plc (OTCMKTS:LDSCY – Get Free Report) was the recipient of a significant drop in short interest during the month of November. As of November 15th, there was short interest totalling 400 shares, a drop of 66.7% from the October 31st total of 1,200 shares. Based on an average daily trading volume, of 8,900 shares, the short-interest ratio is presently 0.0 days.
Land Securities Group Price Performance
Shares of OTCMKTS:LDSCY traded up $0.08 during midday trading on Wednesday, reaching $8.35. 4,297 shares of the company were exchanged, compared to its average volume of 5,126. The business’s fifty day moving average is $8.37 and its two-hundred day moving average is $8.35. Land Securities Group has a one year low of $7.16 and a one year high of $10.05.
Land Securities Group Cuts Dividend
The company also recently declared a dividend, which will be paid on Thursday, January 23rd. Investors of record on Friday, November 29th will be paid a dividend of $0.0712 per share. The ex-dividend date is Friday, November 29th.
About Land Securities Group
At Landsec, we build and invest in buildings, spaces and partnerships to create sustainable places, connect communities and realise potential. We are one of the largest real estate companies in Europe, with a £12 billion portfolio of retail, leisure, workspace and residential hubs. Landsec is shaping a better future by leading our industry on environmental and social sustainability while delivering value for our shareholders, great experiences for our guests and positive change for our communities.
Featured Articles
- Five stocks we like better than Land Securities Group
- What is MarketRank™? How to Use it
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What to Know About Investing in Penny Stocks
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Breakout Stocks: What They Are and How to Identify Them
- 2 Generic Drug Stocks Ready to Surge in 2025